Related Experiment Video
Updated: Jun 30, 2025

Characterization of the Isolated, Ventilated, and Instrumented Mouse Lung Perfused with Pulsatile Flow
Published on: April 29, 2011
Pulmonary Vascular Dysfunctions in Cystic Fibrosis
Jean-Pierre Amoakon1,2, Goutham Mylavarapu3, Raouf S Amin3
1Department of Systems Biology and Physiology, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States.
Cystic fibrosis (CF) affects the lungs due to mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. New research highlights CFTR
Area of Science:
- Pulmonary vascular medicine
- Cell biology
- Genetics
Background:
- Cystic fibrosis (CF) is an inherited disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
- CFTR protein functions as a chloride channel, impacting various organs, especially the lungs.
- Historically, CF research focused on airway epithelium, but CFTR is also present and functional in endothelial cells.
Purpose of the Study:
- To elucidate the role of CFTR in the endothelium.
- To understand how defective CFTR impacts pulmonary vasculature and lung function.
- To summarize current knowledge on pulmonary vascular dysfunctions in CF and discuss therapies.
Main Methods:
- Review of current literature on CFTR function in endothelial cells.
- Analysis of research linking CFTR to vascular dysfunctions.
- Synthesis of information on therapeutic approaches.
Main Results:
- CFTR is expressed and functional on endothelial cells.
- Defective CFTR contributes to vascular dysfunctions in CF.
- Several pulmonary vascular dysfunctions associated with CF have been identified.
Conclusions:
- Understanding CFTR's role in the endothelium is crucial for comprehending CF pathogenesis.
- Targeting CFTR in the endothelium may offer new therapeutic strategies for CF-related vascular issues.
- Further research is needed to fully elucidate the impact of CFTR on pulmonary vasculature.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...

